Invention Grant
- Patent Title: Marker adapted normal tissue complication probability
- Patent Title (中): 标记适应正常组织并发症概率
-
Application No.: US13256767Application Date: 2010-02-18
-
Publication No.: US09248313B2Publication Date: 2016-02-02
- Inventor: Martin Weibrecht , Jens Christoph Georgi , Carolina M. Ribbing
- Applicant: Martin Weibrecht , Jens Christoph Georgi , Carolina M. Ribbing
- Applicant Address: NL Eindhoven
- Assignee: KONINKLIJKE PHILIPS N.V.
- Current Assignee: KONINKLIJKE PHILIPS N.V.
- Current Assignee Address: NL Eindhoven
- International Application: PCT/IB2010/050732 WO 20100218
- International Announcement: WO2010/109357 WO 20100930
- Main IPC: A61N5/00
- IPC: A61N5/00 ; A61N5/10 ; G06Q50/22

Abstract:
A therapy system includes a diagnostic image scanner (12) that acquires a diagnostic image of a target region to be treated. A planning processor (70) is configured to generate a patient specific adaptive radiation therapy plan based on patient specific biomarkers before and during therapy. A first set of patient specific biomarkers is determined then used for the determination of a first normal tissue complication probability (NTCP) model and a first tumor control probability (TCP) model. A radiation therapy device (40) administers a first dose of radiation to the target region with a protocol based on the first NTCP model and the first TCP model. A second set of patient specific biomarkers is determined. A relationship between the first set and second set of patient specific biomarkers is used to determine a second NTCP model and a second TCP model. The radiation therapy device (40) administers a second dose of radiation to the target region with a protocol based on the second NTCP model and second TCP model.
Public/Granted literature
- US20120004492A1 MARKER ADAPTED NORMAL TISSUE COMPLICATION PROBABILITY Public/Granted day:2012-01-05
Information query